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Abstract
Background and Aims—Little is known about the association between obesity and bowel
preparation. We investigated whether body-mass index (BMI) is an independent risk factor for
inadequate bowel preparation in patients who receive split preparation regimens.
Methods—We performed a retrospective study of data from 2163 consecutive patients (mean
age, 60.6 ± 10.5 y; 93.8% male) who received outpatient colonoscopies in 2009 at the Veterans
Affairs Medical Center in Indianapolis, Indiana. All received a split preparation, categorized as
adequate (excellent or good, based on the Aronchick scale) or inadequate. We performed
multivariable analysis to identify factors independently associated with inadequate preparation.
Results—Bowel preparation quality was inadequate for 44.2% of patients; these patients had
significantly higher mean BMIs than patients with adequate preparation (31.2±6.5 vs 29.8±5.9,
respectively; P<.0001) and Charlson comorbidity scores (1.5±1.6 vs 1.1±1.4; P<.0001).
Independent risk factors for inadequate preparation were BMI ≥ 30 kg/m2 (odds ratio [OR], 1.46;
95% confidence interval [CI], 1.21–1.75; P <.0001), use of tobacco (OR, 1.28; 95% CI, 1.07–1.54;
P=.0084) or narcotics (OR, 1.28; 95% CI, 1.04–1.57; P=.0179), hypertension (OR, 1.30; 95% CI,
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1.07–1.57; P=.0085), diabetes (OR, 1.38; 95% CI, 1.12–1.69; P=.0021), and dementia (OR, 3.02;
95% CI, 1.22–7.49; P=.0169).
Conclusions—BMI is an independent factor associated with inadequate split bowel preparation
for colonoscopy. Additional factors associated with quality of bowel preparation include diabetes,
hypertension, dementia, and use of tobacco and narcotics. Patients with BMIs ≥ 30 kg/m2 should
be considered for more intensive preparation regimens.
Keywords
Colonoscopy preparation; colorectal cancer screening; overweight; adenoma detection
Introduction
Colonoscopy is a powerful tool for colorectal cancer (CRC) prevention, as it allows the
detection and removal of precursor adenomatous polyps. The effectiveness of colonoscopy
depends on several factors, foremost of which is the adequacy of visualization of the colonic
mucosa, allowing a thorough inspection for colon neoplasms. Studies have shown that a
poor bowel preparation is associated with lower adenoma detection rates (1, 2).
Despite the importance of preparation quality, there is no widely accepted definition of the
precise characteristics of an adequate bowel preparation. The U.S. Multi-Society Task Force
on Colorectal Cancer, and the ASGE/ACG Taskforce on Quality in Endoscopy state that an
adequate preparation is one in which polyps >5 mm can be reliably visualized (3, 4). A 2010
meta-analysis showed that about 25% of patients do not achieve adequate preparation
quality with polyethylene glycol-based bowel preparations (5). Tailored preparation
regimens would certainly be beneficial in these patients, if they could be identified prior to
their procedure.
Obesity is one risk factor among several that is associated with unsatisfactory bowel
preparation (6), although whether this applies to split dose regimens is uncertain. Split dose
preparations, where a portion of the preparation is given on the day of the examination, are
essential for adequate preparation quality and have become the standard in clinical practice
(7-9). Split-dose preparations increase the proportion of adequate preparation quality,
increase patient compliance, and improve patient tolerance (10). Other variables associated
with inadequate bowel preparation are male gender, older age, constipation, diabetes,
dementia, history of stroke, liver cirrhosis, use of tricyclic agents and unfavorable
socioeconomic conditions (11-15). However, it is also not clear if these risk factors are
pertinent to split-dose preparations.
Our aim was to determine whether body-mass index (BMI) is an independent risk factor for
inadequate preparation in patients who receive a split preparation regimen.
Materials and Methods
Population Description
This retrospective cross-sectional study was conducted at the Richard L. Roudebush
Veterans Affairs Medical Center (VAMC) in Indianapolis, Indiana, a tertiary care academic
VAMC affiliated with Indiana University. Consecutive patients who underwent colonoscopy
between 1/1/2009 and 12/31/2009 were considered for inclusion. The study was approved
by the Indiana University Institutional Review Board and the Roudebush VAMC Research
and Development Board. Patients were identified by querying the VA computerized patient
record system (CPRS). Subjects were eligible for inclusion if they underwent elective
outpatient colonoscopy during the study period. In the event that a patient underwent more
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than one colonoscopy, the first procedure only was included. Exclusion criteria consisted of
patients with a prior colon resection; colonoscopies that were repeated within the study
period due to prior poor bowel preparation; colonoscopies performed emergently, in
hospitalized patients, after a two-day bowel preparation, or in underweight patients (BMI <
18.5 mg/m2, as these patients may be more likely to have underlying physical or
psychological comorbidities that could preclude successful completion of the preparation
and introduce unknown confounders to the analysis); and incomplete colonoscopies for
reasons other than inadequate preparation (cecum not reached due to factors not related to
bowel preparation).
Bowel Preparation Description
All patients received a polyethylene glycol-based split bowel preparation. The standard
bowel preparation was a split 4 liters of Colyte® (Alaven Pharmaceutical, Marietta, GA); 2
to 3 liters were consumed the evening prior to the procedure (along with 20 mg of
Bisacodyl), and the remaining 1 to 2 liters were taken 4 hours prior to the colonoscopy. Two
alternative split preparations were also used: MoviPrep® (Salix Pharmaceuticals, Raleigh,
NC), with 1 liter consumed the evening prior to the exam, and the second liter 4 hours ahead
of the colonoscopy; or MiraLax® (Merck, Whitehouse Station, NJ), with 119 g consumed
the evening before the test (along with 10 mg of Bisacodyl) and another 119 g taken 4 hours
before undergoing the colonoscopy.
Data Collection
The VA CPRS electronic medical records include demographic and clinical information.
Our colonoscopy reports are generated using the Provation® system (Minneapolis, MN) and
recorded in CPRS. Patient data collected included: demographic variables- age, gender, race,
ethnicity, weight, height and BMI; comorbidities- coronary artery disease, congestive heart
failure, diabetes mellitus, hypertension, stroke, dementia, liver cirrhosis, comorbidity count,
and comorbidity burden using the Charlson comorbidity score (16); pertinent medication
use- narcotics, calcium channel blockers, iron supplements, anticonvulsants and medications
with anticholinergic properties (antispasmodics, antipsychotics, tricyclic agents and
antiparkinsonian drugs); tobacco and alcohol use (excessive alcohol use was based on
history of alcoholism, recurrent binge drinking or consuming regularly more than 2 drinks
per day); and type of bowel preparation used. Colonoscopy data collected included:
procedure indication, family history of colon cancer, bowel preparation type and quality, and
findings. Preparation quality is subjectively assessed at our institution by each individual
endoscopist according to the Aronchick scale: excellent, good, fair, poor and unsatisfactory
(17). Colonoscopy findings recorded included presence of polyps, number, size, location and
histology. The recommended follow-up colonoscopy interval was recorded, including
whether the interval was shortened due to the preparation quality.
Statistical Analysis
Subjects were categorized based upon their colonoscopy preparation quality into two
groups: adequate preparation (excellent or good preparation on the Aronchick scale) or
inadequate preparation (fair, poor or unsatisfactory preparation). T-tests and Fisher’s exact
tests were used to compare both groups. BMI was categorized as normal (18.5 to 24.9 kg/
m2); overweight (BMI between 25 and 30 kg/m2) or obese (BMI over 30 kg/m2). Logistic
regression was used to model the association of BMI with inadequate preparation quality,
which was done treating BMI both as a continuous and a categorical variable. From each
model, Receiver Operator Characteristics (ROC) curves were generated and area under the
curve (AUC) was measured to help determine an optimal BMI cutoff. Multivariable logistic
regression analysis was performed to determine factors independently associated with
inadequate preparation quality, with candidate variables having univariate p-values <0.20.
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Multivariable logistic regression was also used to obtain and compare estimates of the
adenoma detection rate for adequate and inadequate preparation quality, after adjusting for
the terms in the final model on inadequate preparation quality.
Results
During the study period, 3124 subjects underwent colonoscopy, of which 700 (22.4%) were
excluded due to the following reasons: hospitalized status or emergent procedure (n=256;
36.6%), incomplete colonoscopy (unrelated to preparation) (n=21; 3.0%), repeat
colonoscopy due to poor preparation earlier in 2009 (n=71; 10.1%), colonoscopy following
a 2-day preparation (n=155; 22.1%), subjects not undergoing a split preparation (n=8;
1.1%), prior colon resection (n=168; 24.0%), and underweight (BMI < 18.5 kg/m2) (n=21;
3.0%). An additional 261 were excluded due to preparation quality not documented in the
colonoscopy report (n=41), unavailable BMI data (n=209), and incomplete medical records
(n=11). Overall, 2163 subjects were included in the analysis. All colonoscopies were
performed by one of seven staff endoscopists.
Basic Characteristics
Mean age of subjects in the study cohort was 60.6 ± 10.5 years; 93.8% were male; 82.5%
were Caucasian. The mean Charlson score was 1.3 ± 1.5. Three hundred eighty-one patients
(17.6%) had a normal BMI; 774 (35.8%) were overweight and 1008 (46.6%) were obese.
Colonoscopy was performed for colorectal cancer screening in 746 patients (34.6%) and
surveillance in 737 patients (34.1%); the remainder 675 cases (31.3%) were diagnostic
colonoscopies, including 22 procedures performed to evaluate constipation (1.0%). Most
patients received a split Colyte® preparation (n=1953; 91.1%); 45 subjects (2.1%) received
MoviPrep® and 146 subjects (6.8%) received MiraLax® preparation.
Preparation quality was characterized as excellent in 26 subjects (1.2%), good in 1181
(54.6%), fair in 680 (31.4%), poor in 246 (11.4%), and unsatisfactory in 30 subjects (1.4%).
When the preparation variable was dichotomized, there were 1207 subjects (55.8%) with
adequate preparation quality and 956 (44.2%) with inadequate preparation quality. There
was no statistically significant difference between the two groups for gender, race, ethnicity,
family history of colorectal cancer, or bowel preparation type. There were minor differences
between both groups for age, tobacco and alcohol use. The proportion of patients who were
undergoing colonoscopy for diagnostic indications, was slightly higher in the inadequate
preparation quality group (Table 1).
Univariate Analysis
Mean BMI in the group of patients with inadequate bowel preparation quality was
significantly higher than in the adequate preparation quality group: 31.2 ± 6.5 kg/m2 versus
29.8 ± 5.9 kg/m2 (p<0.0001) (Table 1). Among subjects with inadequate bowel preparation
quality, 53.0% were obese as compared with 41.5% of those with adequate preparation
quality (p<0.0001). Subjects with inadequate bowel preparation quality also had
significantly more comorbidities and a higher mean Charlson score compared to those with
adequate preparation quality. When specific comorbidities were assessed, those with
inadequate preparation quality had higher rates of coronary artery disease, congestive heart
failure, diabetes, hypertension, and dementia. In addition, more subjects with inadequate
preparation quality were using narcotics or calcium channel blockers (Table 2).
Univariate logistic regression found that obese patients had a significantly higher risk for
inadequate preparation quality compared to both overweight subjects and normal BMI
(Table 3). Similarly, BMI treated as a continuous variable was significantly associated with
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inadequate preparation quality. Using a BMI cutoff point of 30 kg/m2 maximizes the AUC
at 0.558 (OR: 1.59; 95% CI: 1.34-1.89; p<0.0001).
Multivariate Results
Multivariable logistic regression analysis found that a BMI of ≥ 30 kg/m2 was an
independent risk factor for inadequate bowel preparation quality (OR: 1.46; 95% CI:
1.21-1.75; p<0.0001). In addition to BMI, hypertension, diabetes, dementia, tobacco use,
and narcotics, were independent risk factors for inadequate bowel preparation quality (Table
4). The multivariate logistic regression analysis was run with and without preparation type
(Colyte® vs MoviPrep® vs MiraLax®) in the model. Including the type of preparation
taken by the patient in the model had no clinically important or statistically significant
changes in the odds ratios for the independent variables.
Procedure Outcomes
There was no significant difference in polyp detection rate or adenoma detection rate (ADR)
between the 2 groups (ADR 50.2% in the adequate preparation quality group, ADR 48.2%
in the inadequate preparation quality group; p=0.35), after adjusting for BMI, tobacco and
narcotics use, hypertension, diabetes and dementia. However, there was a significant impact
of preparation quality on aborted procedures and follow-up intervals. No procedures (0%)
were aborted in patients with adequate preparation quality, whereas 60 colonoscopies (6.3%)
were aborted among those with inadequate preparation quality (p<0.0001). Further, the
follow up colonoscopy interval was shortened specifically due to preparation quality in 6
patients with adequate preparation (0.5%) as compared with 554 patients (58.5%) with
inadequate preparation quality (p<0.0001). Mean follow up interval was almost twice as
long following an adequate preparation as compared to inadequate preparation quality: 56.7
± 64.1 months vs 30.2 ± 48.2 months (p<0.0001).
Discussion
In this study, we found that obesity is an independent risk factor for inadequate bowel
preparation quality in patients who receive split-dose regimens. A BMI ≥ 30 kg/m2 was an
independent risk factor for inadequate preparation quality. Independent of obesity, we also
found that tobacco use, narcotic medications, hypertension, diabetes and dementia were
associated with inadequate preparation.
Our results are consistent with previous studies that evaluated risk factors for inadequate
preparation quality (6, 11-15, 18) (Table 5). Some variation is likely related to different
study designs, study populations, definitions of inadequate preparation quality, and most
importantly, the fact that our study is the first to strictly assess split-dose bowel preparation.
An indication of constipation was found to be associated with increased likelihood of
inadequate preparation quality in the study by Ness et al. (11), but not in our study, Lebwohl
et al.’s (14) and Borg et al.’s (6) studies. Evaluating for most socioeconomic factors was not
applicable to our study, as it was conducted at a VAMC; unmarried status and Medicaid
insurance are the main socioeconomic predictors in other studies (14, 15). Similarly, we
were not able to assess male gender as our cohort consisted largely of males. Consistent with
our findings, Borg et al. (6) found that a BMI ≥ 30 kg/m2 was an independent predictor of
inadequate bowel preparation (OR 1.35; 95% CI: 1.09-1.68; p=0.006). In a recent Australian
study, sodium picosulphate bowel preparation was prospectively assessed in 99 patients,
36% of whom were obese (19). There was no difference in good preparation quality between
obese and non-obese patients (89% vs 90% respectively; p>0.99), and the authors concluded
that a sodium picosulphate preparation is an excellent bowel preparation solution for obese
patients.
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Our study has several strengths. This is the first study where all included subjects received a
split-dose bowel preparation. The sample in our study is large and the study population is
homogeneous. The study was conducted in the VA system, which represents the largest
single provider of healthcare in the United Sates, and the second largest payor for health
services after Medicare.
Our study also has limitations. This study is retrospective in design, and 261 subjects
(10.8%) were excluded due to relevant missing data. However, our final cohort included
over 2000 subjects, and while we were unable to compare those excluded to the analyzed
cohort, there is no reason to suspect that they would differ significantly. Our study is also a
single center study from an academic VA medical center; thus, the generalizability of our
results could be questioned, although they agree with the published literature in other
populations. In addition, we recognize that the determination of preparation quality can vary
significantly among endoscopists, particularly the definition of a fair preparation. Further,
the colonoscopy reports did not routinely specify if preparation quality was ultimately
documented based on the assessment preceding or following lavage and suction. While the
use of the Boston bowel preparation scale (BBPS) has less interobserver variability (20), it is
more cumbersome and reflects less the clinical practice compared to the Aronchick scale
(17), which is used at our institution. Finally, the overall rate of inadequate preparation
quality is higher in our study compared to other studies, reflecting some characteristics of
our cohort, specifically, a strong male predominance and older age, and possibly due to the
inclusion in the inadequate preparation group of fair preparations, a determination that is
variable and subjective among endoscopists.
The effectiveness of colonoscopy depends largely on the quality of bowel preparation. In a
recent study by Lebwohl et al., the adenoma miss rate due to suboptimal bowel preparation
ranged between 35% and 42% (21). With an estimated 25% of patients or more not
achieving adequate preparation quality for their colonoscopy (1, 5, 22), this represents a
considerable barrier to optimizing colorectal cancer screening and surveillance, and a
primary reason for aborting procedures and/or repeating them at a shorter interval that
guidelines recommend (2, 23). The importance of an adequate bowel preparation quality in
obese patients is particularly important, in light of the increasing incidence of obesity in the
United States and worldwide, as well as the increased prevalence of colonic adenomas
amongst obese patients, which was confirmed in two recent meta-analyses (24, 25).
Recognizing other predictors of inadequate bowel preparation is similarly important, in
order to tailor the preparation based on the assessment of all potential factors that could limit
the success of a standard bowel preparation. A more intensive preparation regimen could be
considered in patients with a BMI ≥ 30 kg/m2. Measures to improve the preparation quality
include a double dose of polyethylene glycol over 2 days, the choice of an alternative
product, the addition of another cathartic, longer period of dietary restriction (low residue
diet and clear liquid diet), as well as patient education endeavors to optimize understanding
and compliance. According to a report by the Centers for Disease Control and Prevention
(CDC), the burden of obesity on healthcare spending continues to increase, accounting for
9.1% of the annual medical spending in 2008 (about $147 billion dollars in a year) (26). Rex
et al. have shown that imperfect bowel preparation increases colonoscopy costs by 12% to
22%, given aborted examinations, as well as completed examinations with suboptimal
preparation requiring shortened follow up (27). Improving the effectiveness of colonoscopy
in obese patients could contribute to reducing healthcare cost increments, by reducing the
frequency of aborted and/or repeated procedures due to inadequate preparation quality, and
importantly, by decreasing the incidence of colorectal cancer in obese patients.
In conclusion, BMI is an independent risk factor for inadequate colonoscopy preparation
quality among patients using split bowel preparations. Diabetes, hypertension, dementia,
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tobacco use and narcotic medications are additional risks factors that help identify patients
who are also likely to require tailored preparations. A BMI ≥ 30 kg/m2should prompt
consideration of a more intensive preparation regimen. Future efforts are necessary to
establish and validate better preparation regimens, particularly in patients with high BMI
and those with multiple predictors of unsatisfactory preparation. Improved bowel
preparation results can lead to more rational and economical utilization of health care
resources for prevention and early detection of colorectal cancer.
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Table 1
Characteristics of Patients with Adequate and Inadequate Preparation Quality.
All Subjects (n=2163) Adequate Preparation Quality
(n=1207)
Inadequate Preparation
Quality (n=956)
p-value
Male gender, n (%) 2008 (93.8%) 1110 (93.0%) 898 (94.9%) 0.0701
Age (years), mean ± SD 60.6 ± 10.5 60.2 ± 10.8 61.1 ± 10.0 0.0430
Race, n (%) 0.3045
 White 1587 (82.5%) 876 (81.7%) 711 (83.5%)
 Non-White 336 (17.5%) 196 (18.3%) 140 (16.5%)
Hispanic, n (%) 12 (0.7%) 6 (0.6%) 6 (0.75%) 0.7749
BMI, n (%) <0.0001
 Normal 381 (17.6%) 233 (19.3%) 148 (15.5%)
 Overweight 774 (35.8%) 473 (39.2%) 301 (31.5%)
 Obese 1008 (46.6%) 501 (41.5%) 507 (53.0%)
BMI (Kg/m2), mean ± SD 30.4 ± 6.2 29.8 ± 5.9 31.2 ± 6.5 <0.0001
Tobacco Use, n (%) 848 (39.4%) 447 (37.2%) 401 (42.2%) 0.0209
Alcohol Use, n (%) 0.0297
 Excessive 191 (8.9%) 105 (8.8%) 86 (9.1%)
 Social 704 (32.9%) 422 (35.3%) 282 (29.9%)
 No use 1244 (58.2%) 669 (55.9%) 575 (61.0%)
Family history of CRC, n (%) 205 (9.6%) 119 (9.9%) 87 (9.2%) 0.6057
Colonoscopy Indication, n (%) 0.0209
Screening 746 (34.6%) 446 (37.0%) 300 (31.4%)
 Surveillance 737 (34.1%) 401 (33.3%) 336 (35.2%)
 Diagnostic 675 (31.3%) 357 (29.7%) 318 (33.4%)
  *Constipation 22 (1.0%) 11 (0.9%) 11 (1.2%)
Preparation Type, n (%) 0.5976
 Colyte® 1953 (91.1%) 1098 (91.5%) 855 (90.6%)
 MoviPrep® 45 (2.1%) 26 (2.2%) 19 (2.0%)
 MiraLax® 146 (6.8%) 76 (6.3%) 70 (7.4%)
SD, Standard Deviation; BMI, Body Mass Index; CRC, Colorectal Cancer
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Table 2
Comorbidities and Medications Use in Patients with Adequate and Inadequate Preparation Quality.
All Subjects (n=2163) Adequate Preparation
Quality (n=1207)
Inadequate Preparation
Quality (n=956)
p-value
Comorbidities
Coronary Artery Disease, n (%) 428 (20.3%) 209 (17.8%) 219 (23.5%) 0.0015
Congestive Heart Failure, n (%) 124 (5.9%) 58 (5.0%) 66 (7.1%) 0.0403
Diabetes, n (%) 638 (30.2%) 307 (26.0%) 331 (35.5%) <0.0001
Hypertension, n (%) 1403 (65.5%) 737 (61.7%) 666 (70.3%) <0.0001
Dementia, n (%) 27 (1.3%) 9 (0.8%) 18 (1.9%) 0.0198
Stroke, n (%) 100 (4.8%) 48 (4.1%) 52 (5.6%) 0.1217
Liver Cirrhosis, n (%) 53 (2.5%) 24 (2.1%) 29 (3.1%) 0.1247
Number of comorbidities, mean ± SD 1.0 ± 1.1 0.9 ± 1.1 1.2 ± 1.2 <0.0001
Charlson index, mean ± SD 1.3 ± 1.5 1.1 ± 1.4 1.5 ± 1.6 <0.0001
Pertinent Medications
Narcotics, n (%) 556 (25.7%) 285 (23.6%) 271 (28.3%) 0.0132
Calcium Channel Blockers, n (%) 339 (15.7%) 170 (14.1%) 169 (17.7%) 0.0237
Anticholinergics, n (%) 428 (19.8%) 224 (18.6%) 204 (21.3%) 0.1151
Iron Supplements, n (%) 121 (5.6%) 64 (5.3%) 57 (6.0%) 0.5112
Anticonvulsants, n (%) 69 (3.2%) 31 (2.6%) 38 (4.0%) 0.0839
SD, Standard Deviation
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Table 3
Univariate Logistic Regression of Association of BMI and Inadequate Bowel Preparation Quality.
OR 95% CI p-value
BMI (Kg/m2)- continuous 1.04 1.02-1.05 <0.0001
Overweight vs Normal BMI 1.00 0.78-1.28 0.9887
Obese vs Normal BMI 1.59 1. 25-2.03 0.0001
Obese vs Overweight 1.59 1.32-1.92 <0.0001
OR, Odds Ratio; CI, Confidence Interval
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Table 4
Independent Risk Factors for Inadequate Bowel Preparation Quality*.
OR 95% CI p-value
BMI ≥ 30 Kg/m2 1.46 1.21-1.75 <0.0001
Tobacco use 1.28 1.07-1.54 0.0084
Narcotics use 1.28 1.04-1.57 0.0179
Hypertension 1.30 1.07-1.57 0.0085
Diabetes 1.38 1.12-1.69 0.0021
Dementia 3.02 1.22-7.49 0.0169
OR, Odds Ratio; CI, Confidence Interval
*
Results from final multivariable logistic regression model.
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